Nurse-led PrEP program for people in prison
Part of Infections clinical trials.
This study tests a nurse-led program to help people in prison start taking PrEP, a daily pill that prevents HIV. It aims to make starting PrEP easier and more supportive while you're incarcerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently at the Rhode Island Department of Corrections.
- You are at least 18 years old.
- You are not pregnant.
- You have not used PrEP in the 90 days before coming to prison.
- You are interested in starting PrEP.
- You used drugs that are not legal or had at least one heavy drinking day in the 90 days before prison.
- You expect to be in prison for more than a week but less than 6 months.
- You can understand and speak English and can give written and spoken consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a counseling program to help more people who could benefit from PrEP (a pill that prevents HIV) actually start taking it. If you're a healthcare provider or someone looking for HIV prevention, this study might help improve access to PrEP.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This trial helps people recently involved with the justice system and who use stimulants or opioids decide on HIV prevention or treatment. It tests a shared decision-making approach for taking HIV medication (ART) or PrEP.
This study helps men recently released from jail who inject drugs to start and stay on PrEP, a daily medicine that prevents HIV. The goal is to support them in taking PrEP regularly and staying connected to care.
This study tests a better way to start long-acting HIV prevention (PrEP) and buprenorphine for opioid use disorder while people are in jail, to see if it helps them stay healthy after release. If you are soon leaving jail and have opioid use disorder, you may be able to join.
Hear when a new HIV Prevention Program trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.